Project Grant R61DA062351
Award Date
9/30/24
Completion Date
8/31/26
Dollars Obligated
$844K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $297,061 to Boulder Care, Inc. to develop and test telehealth workflows for delivering buprenorphine treatment for opioid use disorder (OUD) in high-risk settings. The key products and services to be delivered include: Establishing 5 partnerships to develop and test telehealth workflows for providing buprenorphine treatment in settings such...
This $2,729,018 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development and evaluation of a mobile health intervention for individuals with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The project aims to use a ground-up approach to rigorously develop a mobile app with on-demand 24/7...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $776,368 to the Icahn School of Medicine at Mount Sinai to develop and pilot test a tele-buprenorphine intervention to improve post-incarceration treatment engagement for individuals with opioid use disorder (OUD). The key objectives are to: 1) identify predictors of post-release buprenorphine treatment linkage, 2) incorporate stakeholder...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $106,714 to support a dissertation project examining the impact of the criminal legal system on opioid use disorder (OUD) treatment and recovery. The key objectives of the project are to: 1) Analyze the influence of the criminal legal system on the language used to discuss OUD treatment and recovery in high-impact communities, 2) Assess the...
This $1,377,306 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Grant Program "Drug Use and Addiction Research Programs" (CFDA 93.279), will fund a multi-jurisdictional study aimed at transforming the evidence base on the prevalence of opioid use disorder (OUD) and the impact of opioid agonist treatment (OAT) in preventing opioid-related deaths. The study will leverage data linkages across sites in the U.S. (Rhode Island, Wisconsin, Colorado, and...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to establish an evidence base for improving the utility of urine drug testing (UDT) in opioid use disorder (OUD) treatment. The $2,730,450 project will characterize variation in real-world UDT use, identify distinct trajectories of drug positivity during OUD treatment, and estimate the association between UDT use, substance positivity, and...
This $123,930 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will enhance the research career of the Principal Investigator (PI) by providing four years of training and support to integrate implementation science approaches into their ongoing research portfolio. The PI, an emergency medicine physician, will leverage an existing R01-funded randomized trial evaluating an embedded emergency department physical...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $189,896 to develop and pilot test the "Patient Reported Outcome Measures to Individualize Treatment and Improve Retention" (RETAIN) program intervention package. The goal is to capture patient-reported outcome measures (PROMs) in Federally Qualified Health Center (FQHC)-based opioid use disorder (OUD) treatment, with the objective of...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the CFDA 93.279 Drug Use and Addiction Research Programs, will evaluate the real-world effectiveness of telehealth-delivered buprenorphine (tele-buprenorphine) for treating opioid use disorder. The $1,503,086 project aims to develop clinical guidance on optimizing tele-buprenorphine care, including evaluating its effectiveness for high-risk and underserved populations. The project uses a mixed-methods approach,...
This Project Grant award in the amount of $2,467,574.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant funds the development and evaluation of a universal overdose prevention intervention to be delivered in primary care settings to youth ages 13-26. The key products and services include: Development of an overdose prevention intervention using the Informational-Motivational-Behavioral Skills Model in...